The starch cook, and the enzymes engineered to work around it
1 / 8
A corn dry-grind plant cooks its mash at 85–105 °C so α-amylase can liquefy the starch, then doses glucoamylase to saccharify the dextrins to glucose. The cook carries a measurable cost. Amylose-lipid complexes form above 85 °C and cut available starch from 73% to 61% across liquefaction, and α-amylase loses 73% of its activity in the first hour at 90 °C.
The product claims rest on the suppliers' own numbers
2 / 8
The yeast and enzyme products are sold on figures their makers publish. IFF reports that industry yield rose 10% between 2015 and 2024 while corn use rose 5%. That is a supplier's framing of an industry-wide trend.
Strategy
The enzyme purchase is the line every product bet attacks
3 / 8
Every product bet in this field converges on one cost line: what a plant pays for purified enzyme. The yeast makers engineer the enzyme into the organism so less is bought. The seed companies put it in the corn. The enzyme suppliers build on-site manufacturing to make it cheaper. The research literature reads as pre-commercial, but the filings show the strain-engineering route is the incumbents' product line.
Research
The enzyme step is moving into the yeast
4 / 8
The most advanced line puts the glucoamylase gene into the fermenting yeast so the plant buys less purified enzyme. The constructs are specific. Cargill claims secreted glucoamylase with modified signal sequences that push ethanol above 90 g/L. Novozymes claims yeast expressing glucoamylase or α-amylase. Lallemand and BASF claim a process whose stated purpose is to displace the exogenous enzyme. Xylogenics claims a strain that ferments corn mash with no supplemental glucoamylase at all, and Angel Yeast claims a strain co-expressing α-amylase and glucoamylase.
Market
The enzyme market grows in value while the dose per gallon falls
5 / 8
US alcohol enzymes were worth roughly $780–850 million in 2026, with fuel ethanol taking more than 60% of demand. Dosage per gallon keeps falling, so the market grows by value. Globally, starch-based enzymes for fuel ethanol were about $1.03 billion in 2025.
Strategy
Suppliers are selling the organism as part of a package
6 / 8
The unit of sale is widening. Lallemand paired its yeast with Braskem's separation hardware to coproduce bio-acetone inside existing plants, with industrial-scale availability targeted for 2028. IFF sells yeast alongside a diagnostic service that maps where distillers corn oil is lost. A plant that adopts the yeast also commits to the partner's hardware, which raises the cost of switching later.
Research
Oxidative cleavage opens crystalline cellulose
7 / 8
Ordinary cellulases cannot reach crystalline cellulose. Lytic polysaccharide monooxygenases (LPMOs) are copper-dependent enzymes that oxidize the C1 or C4 carbon of a sugar unit and break the glycosidic bond, creating chain ends the hydrolytic cellulases can attack. The reaction needs an electron donor, and how that donor is supplied is the engineering problem.
Strategy
Enzyme capacity is being built locally in the growth markets
8 / 8
India is the clearest case. Fermbox signed a supply contract with an Indian 2G producer in April 2025, then a memorandum with Numaligarh Refinery in January 2026 to explore a co-located enzyme plant in Assam, claiming up to 40% cost reduction. The BioE3 policy and the Department of Biotechnology back domestic enzyme manufacturing. The barrier in these markets is moving from enzyme technology to capital and local execution.